The Big Book Of Case Studies

The next generation of clinical trials will be faster, more efficient, and produce higher quality patient outcomes. To support your business goals, help you think more strategically about the impact of the right technological approach to next-generation trial execution, and to help your business deliver more in the next decade, Medidata has designed three technology strategies to help modernize your trials - Improving Patient Experience, Ensuring Effective Management, and Simplifying Data Complexity. Focused on patients, processes, and data, each strategy is designed to seamlessly work across your teams and business areas and each can be adopted one at a time or all at once.

Modernizing clinical trials is not simply about integrating technology into old ways of conducting trials. Even with regulating functions like the FDA suggesting a number of innovative approaches to run modern clinical trials, there has been a continued reluctance to adopt such approaches among sponsors and CROs. While smaller companies are nimble and hence better suited for innovating and modernizing their trials, they lack the resources and budget needed to move forward with such approaches. Meanwhile, larger companies who have the resources to innovate and modernize have not yet scaled into pivotal studies. Generally, the pharmaceutical industry has been used to taking a “wait and see” approach where they wait for larger companies or one or two early adopters to demonstrate a superior process and manage to get regulatory approval. But this is not a long-term strategy.

Modernizing clinical trials is possible with a focused effort and in this eBook, we present real-life examples of select Medidata customers who have aligned the right technology strategies with their business priorities to optimize trial performance and data quality.